Overview
Dr. Elisa H. Ignatius is an infectious diseases and clinical pharmacology specialist at the Johns Hopkins University School of Medicine. She is an expert in the care of patients with nontuberculous mycobacterial (NTM) infections, tuberculosis (TB), bronchiectasis, HIV/AIDS, and other general infectious diseases. Additionally, she provides teaching for medical students, residents, and fellows at the Johns Hopkins University School of Medicine. Dr. Ignatius earned her M.D. and completed Internal Medicine residency at Emory University School of Medicine. She also obtained a Masters of Science in the Control of Infectious Diseases from the London School of Hygiene and Tropical Medicine, where her research focused on drug-resistant tuberculosis in South Africa. After completing residency, she worked as a co-investigator on HIV prevention clinical trials in Atlanta, Georgia. She then came to Johns Hopkins University where she completed fellowships in both Infectious Diseases and Clinical Pharmacology. Dr. Ignatius’s research interests focus on treatment optimization strategies for mycobacterial infections (NTM and TB), including regimens of novel and standard drugs.
Dr. Ignatius is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease and Osteomyelitis.
Dr. Ignatius is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5501 Hopkins Bayview Circle, Allergy & Asthma Center, 2nd Floor, Allergy & Asthma Center, 2nd Floor, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine.
Office
Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
The Johns Hopkins Hospital
John Baddley is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Baddley is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia. Dr. Baddley is board certified in American Board Of Internal Medicine.
Frequently Asked Questions about Dr. Elisa Ignatius
How do I make an appointment with Dr. Elisa Ignatius?
You can book an appointment with Dr. Elisa Ignatius by calling their office at 410-550-5864. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Elisa Ignatius a top-rated expert for Nontuberculous Mycobacterial Lung Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elisa Ignatius is classified as an Advanced expert for Nontuberculous Mycobacterial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Elisa Ignatius specialize in?
While Dr. Elisa Ignatius is a Infectious Disease, they have specific expertise in Nontuberculous Mycobacterial Lung Disease, Osteomyelitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Elisa Ignatius participate in research or clinical trials?
Yes. Dr. Elisa Ignatius has published 24 articles and abstracts on conditions like Nontuberculous Mycobacterial Lung Disease. You can view a list of Dr. Elisa Ignatius's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Elisa Ignatius accept my insurance?
Dr. Elisa Ignatius accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-550-5864 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Nontuberculous Mycobacterial Lung Disease
- Experienced
- OsteomyelitisDr. Ignatius isExperienced. Learn about Osteomyelitis.